Hepatitis B Virus (HBV) Capsid Inhibitors Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Hepatitis B Virus (HBV) Capsid Inhibitors Market Report 2026

Name: Hepatitis B Virus (HBV) Capsid Inhibitors Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Core Protein Allosteric Modulators (CpAMs), Capsid Assembly Modulators, Other Drug Types), By Application (Chronic Hepatitis B, Acute Hepatitis B, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End-User (Hospitals, Clinics, Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

• Hepatitis B Virus (HBV) Capsid Inhibitors market size has reached to $0.52 billion in 2025

• Expected to grow to $0.98 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%

• Growth Driver: Surge In Hepatitis B Virus (HBV) Infections Fueling The Growth Of The Market Due To Low Vaccination Coverage

• Market Trend: Advancements In HBV Capsid Inhibitors Development

• Asia-Pacific was the largest region in 2025.

What Is Covered Under Hepatitis B Virus (HBV) Capsid Inhibitors Market?

Hepatitis B virus (HBV) capsid inhibitors refer to a class of antiviral agents designed to disrupt the assembly, disassembly, or stability of the viral capsid, which is essential for HBV replication. These inhibitors target the core protein responsible for forming the protective shell around the viral DNA, thereby preventing the production of new infectious particles. By interfering with the capsid formation process, they help reduce viral load and disease progression. HBV capsid inhibitors represent a promising therapeutic approach for achieving a functional cure in chronic hepatitis B infection.

The main drug types of hepatitis B virus (HBV) capsid inhibitors are core protein allosteric modulators (CpAMs), capsid assembly modulators, and others. hepatitis B virus (HBV) capsid inhibitors, also known as core protein allosteric modulators (CpAMs), are antiviral agents that target and disrupt the assembly or stability of the viral capsid, thereby blocking HBV replication and reducing viral activity. The applications involved are chronic hepatitis B, acute hepatitis B, and other applications, and are distributed using hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. The end users include hospitals, clinics, research institutes, and others.

Hepatitis B Virus (HBV) Capsid Inhibitors Market Global Report 2026 Market Report bar graph

What Is The Hepatitis B Virus (HBV) Capsid Inhibitors Market Size and Share 2026?

The hepatitis b virus (hbv) capsid inhibitors market size has grown rapidly in recent years. It will grow from $0.52 billion in 2025 to $0.59 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to global burden of chronic hepatitis b infection, limitations of existing antiviral therapies, early clinical validation of capsid inhibitors, increased virology research funding, growing pharmaceutical pipeline activity.

What Is The Hepatitis B Virus (HBV) Capsid Inhibitors Market Growth Forecast?

The hepatitis b virus (hbv) capsid inhibitors market size is expected to see rapid growth in the next few years. It will grow to $0.98 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to expansion of combination regimens with immunotherapies, rising investment in curative hbv treatments, increasing regulatory approvals for novel antivirals, growing global screening programs, advancement of next-generation capsid inhibitors. Major trends in the forecast period include increasing focus on functional cure strategies for hbv, rising development of capsid assembly modulators, growing combination therapy approaches, expansion of late-stage clinical pipelines, enhanced targeting of viral replication pathways.

Book your 30 minutes free consultation with our research experts

Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Segmentation

1) By Drug Type: Core Protein Allosteric Modulators (CpAMs), Capsid Assembly Modulators, Other Drug Types

2) By Application: Chronic Hepatitis B, Acute Hepatitis B, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Core Protein Allosteric Modulators (CpAMs): Class I Core Protein Allosteric Modulators (CpAMs), Class II Core Protein Allosteric Modulators (CpAMs)

2) By Capsid Assembly Modulators: Direct Capsid Assembly Modulators, Indirect Capsid Assembly Modulators

3) By Other Drug Types: Novel Capsid Inhibitors, Combination Therapies, Experimental Mechanism-Based Inhibitors

What Is The Driver Of The Hepatitis B Virus (HBV) Capsid Inhibitors Market?

The increasing prevalence of hepatitis B virus infections is expected to propel the growth of the hepatitis B virus (HBV) capsid inhibitors market going forward. Hepatitis B Virus (HBV) infections refer to liver infections caused by the hepatitis B virus that can lead to both acute and chronic diseases, spreading through contact with infected blood or bodily fluids and resulting in serious complications such as liver cirrhosis or liver cancer. The increasing prevalence of Hepatitis B Virus (HBV) infections is mainly due to low vaccination coverage, which leaves large portions of the population unprotected and allows the virus to spread more easily through contact with infected blood or bodily fluids. Hepatitis B virus (HBV) capsid inhibitors help hepatitis B virus (HBV) infections by disrupting the formation and assembly of the viral capsid, thereby preventing viral replication and reducing the spread of infection within the body. For instance, in April 2024, according to a report published by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, as of the end of 2022, only 13% of individuals with chronic hepatitis B had been diagnosed, and approximately 3% (7 million) had received antiviral treatment. For hepatitis C, 36% of affected individuals had been diagnosed, with 20% (12.5 million) receiving curative therapy, figures that remain far below the global target of treating 80% of people living with chronic hepatitis B and C by 2030. Therefore, the increasing prevalence of hepatitis B virus infections is driving the growth of the hepatitis B virus (HBV) capsid inhibitors industry.

Key Players In The Global Hepatitis B Virus (HBV) Capsid Inhibitors Market

Major companies operating in the hepatitis b virus (hbv) capsid inhibitors market are Johnson & Johnson, Roche Holding AG, GlaxoSmithKline plc, Gilead Sciences Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Novotech Health Holdings Pte. Ltd, Enanta Pharmaceuticals Inc., Assembly Biosciences Inc., Arbutus Biopharma Corporation, Aligos Therapeutics Inc., Qilu Pharmaceutical Co Ltd., Chia Tai Tianqing Pharmaceutical Group Co Ltd., Hepion Pharmaceuticals Inc., Shanghai Zhimeng Biopharma Inc., Antios Therapeutics, Bluejay Therapeutics Inc., Core Biopharma Inc., Door Pharmaceuticals, Shanghai Longwood Biopharmaceuticals Co. Ltd., Zhimeng Biopharma Inc.

Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Trends and Insights

Major companies operating in the hepatitis B virus (HBV) capsid inhibitors market are focusing on developing advancements such as oral small molecule capsid assembly modulators to enhance antiviral efficacy, improve patient compliance, and achieve sustained viral suppression. Oral small-molecule capsid assembly modulators refer to orally administered antiviral agents that interfere with the assembly of the hepatitis B virus (HBV) capsid, blocking its replication and reducing viral activity in the body. For instance, in July 2024, Aligos Therapeutics, Inc., a US-based clinical-stage biopharmaceutical company, collaborated with Xiamen Amoytop Biotech Co., Ltd., a China-based biopharmaceutical company, to launch a clinical trial to evaluate innovative treatment candidates for chronic hepatitis B (CHB), aiming to leverage its advanced capsid assembly modulator technology to enhance antiviral efficacy and accelerate the development of next-generation HBV therapies. The launch marks a significant step in advancing Aligos’s mission to develop effective and potentially curative treatments for patients suffering from chronic hepatitis B.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Hepatitis B Virus (HBV) Capsid Inhibitors Market?

In October 2023, Gilead Sciences Inc., a US-based biopharmaceutical company, partnered with Assembly Biosciences Inc. to leverage its antiviral expertise alongside Assembly Biosciences Inc.’s innovative capsid inhibitor technology to accelerate the development of next-generation small-molecule antivirals that enhance viral suppression, improve treatment outcomes, and potentially achieve a functional cure for patients living with chronic hepatitis B infection. Assembly Biosciences Inc. is a US-based biotechnology company specializing in the discovery and development of antiviral therapeutics, including novel agents targeting the hepatitis B virus (HBV) and other viral infections.

Regional Insights

Asia-Pacific was the largest region in the hepatitis B virus (HBV) capsid inhibitors market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hepatitis B Virus (HBV) Capsid Inhibitors Market?

The hepatitis B virus (HBV) capsid inhibitors market consists of sales of vebicorvir, bepirovirsen, cavrotolimod, hepcludex, and morphothiadin. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hepatitis B Virus (HBV) Capsid Inhibitors Market Report 2026?

The hepatitis b virus (hbv) capsid inhibitors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hepatitis b virus (hbv) capsid inhibitors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Hepatitis B Virus (HBV) Capsid Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$0.59 billion
Revenue Forecast In 2035	$0.98 billion
Growth Rate	CAGR of 13.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Application, Distribution Channel, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson & Johnson, Roche Holding AG, GlaxoSmithKline plc, Gilead Sciences Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Novotech Health Holdings Pte. Ltd, Enanta Pharmaceuticals Inc., Assembly Biosciences Inc., Arbutus Biopharma Corporation, Aligos The
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Hepatitis B Virus (HBV) Capsid Inhibitors Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Hepatitis B Virus (HBV) Capsid Inhibitors Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Focus On Functional Cure Strategies For Hbv

4.2.2 Rising Development Of Capsid Assembly Modulators

4.2.3 Growing Combination Therapy Approaches

4.2.4 Expansion Of Late-Stage Clinical Pipelines

4.2.5 Enhanced Targeting Of Viral Replication Pathways

5. Hepatitis B Virus (HBV) Capsid Inhibitors Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Research Institutes

5.4 Pharmaceutical Companies

5.5 Specialty Hepatology Centers

6. Hepatitis B Virus (HBV) Capsid Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hepatitis B Virus (HBV) Capsid Inhibitors Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hepatitis B Virus (HBV) Capsid Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Size, Comparisons And Growth Rate Analysis

7.3. Global Hepatitis B Virus (HBV) Capsid Inhibitors Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Hepatitis B Virus (HBV) Capsid Inhibitors Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hepatitis B Virus (HBV) Capsid Inhibitors Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hepatitis B Virus (HBV) Capsid Inhibitors Market Segmentation

9.1. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Core Protein Allosteric Modulators (CpAMs), Capsid Assembly Modulators, Other Drug Types

9.2. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Hepatitis B, Acute Hepatitis B, Other Applications

9.3. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.4. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Research Institutes, Other End-Users

9.5. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Core Protein Allosteric Modulators (CpAMs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Class I Core Protein Allosteric Modulators (CpAMs), Class II Core Protein Allosteric Modulators (CpAMs)

9.6. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Capsid Assembly Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Capsid Assembly Modulators, Indirect Capsid Assembly Modulators

9.7. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Novel Capsid Inhibitors, Combination Therapies, Experimental Mechanism-Based Inhibitors

10. Hepatitis B Virus (HBV) Capsid Inhibitors Market Regional And Country Analysis

10.1. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hepatitis B Virus (HBV) Capsid Inhibitors Market

11.1. Asia-Pacific Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hepatitis B Virus (HBV) Capsid Inhibitors Market

12.1. China Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hepatitis B Virus (HBV) Capsid Inhibitors Market

13.1. India Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hepatitis B Virus (HBV) Capsid Inhibitors Market

14.1. Japan Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

14.2. Japan Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hepatitis B Virus (HBV) Capsid Inhibitors Market

15.1. Australia Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hepatitis B Virus (HBV) Capsid Inhibitors Market

16.1. Indonesia Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hepatitis B Virus (HBV) Capsid Inhibitors Market

17.1. South Korea Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

17.2. South Korea Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hepatitis B Virus (HBV) Capsid Inhibitors Market

18.1. Taiwan Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

18.2. Taiwan Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hepatitis B Virus (HBV) Capsid Inhibitors Market

19.1. South East Asia Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

19.2. South East Asia Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market

20.1. Western Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

20.2. Western Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hepatitis B Virus (HBV) Capsid Inhibitors Market

21.1. UK Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hepatitis B Virus (HBV) Capsid Inhibitors Market

22.1. Germany Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hepatitis B Virus (HBV) Capsid Inhibitors Market

23.1. France Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hepatitis B Virus (HBV) Capsid Inhibitors Market

24.1. Italy Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hepatitis B Virus (HBV) Capsid Inhibitors Market

25.1. Spain Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market

26.1. Eastern Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

26.2. Eastern Europe Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hepatitis B Virus (HBV) Capsid Inhibitors Market

27.1. Russia Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hepatitis B Virus (HBV) Capsid Inhibitors Market

28.1. North America Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

28.2. North America Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hepatitis B Virus (HBV) Capsid Inhibitors Market

29.1. USA Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

29.2. USA Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hepatitis B Virus (HBV) Capsid Inhibitors Market

30.1. Canada Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

30.2. Canada Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hepatitis B Virus (HBV) Capsid Inhibitors Market

31.1. South America Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

31.2. South America Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hepatitis B Virus (HBV) Capsid Inhibitors Market

32.1. Brazil Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hepatitis B Virus (HBV) Capsid Inhibitors Market

33.1. Middle East Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

33.2. Middle East Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hepatitis B Virus (HBV) Capsid Inhibitors Market

34.1. Africa Hepatitis B Virus (HBV) Capsid Inhibitors Market Overview

34.2. Africa Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hepatitis B Virus (HBV) Capsid Inhibitors Market Regulatory and Investment Landscape

36. Hepatitis B Virus (HBV) Capsid Inhibitors Market Competitive Landscape And Company Profiles

36.1. Hepatitis B Virus (HBV) Capsid Inhibitors Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Hepatitis B Virus (HBV) Capsid Inhibitors Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Hepatitis B Virus (HBV) Capsid Inhibitors Market Company Profiles

36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Jiangsu Hengrui Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Hepatitis B Virus (HBV) Capsid Inhibitors Market Other Major And Innovative Companies

Novotech Health Holdings Pte. Ltd, Enanta Pharmaceuticals Inc., Assembly Biosciences Inc., Arbutus Biopharma Corporation, Aligos Therapeutics Inc., Qilu Pharmaceutical Co Ltd., Chia Tai Tianqing Pharmaceutical Group Co Ltd., Hepion Pharmaceuticals Inc., Shanghai Zhimeng Biopharma Inc., Antios Therapeutics, Bluejay Therapeutics Inc., Core Biopharma Inc., Door Pharmaceuticals, Shanghai Longwood Biopharmaceuticals Co. Ltd., Zhimeng Biopharma Inc.

38. Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hepatitis B Virus (HBV) Capsid Inhibitors Market

40. Hepatitis B Virus (HBV) Capsid Inhibitors Market High Potential Countries, Segments and Strategies

40.1 Hepatitis B Virus (HBV) Capsid Inhibitors Market In 2030 - Countries Offering Most New Opportunities

40.2 Hepatitis B Virus (HBV) Capsid Inhibitors Market In 2030 - Segments Offering Most New Opportunities

40.3 Hepatitis B Virus (HBV) Capsid Inhibitors Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Overview Of Key Products - Product Examples

Table 2: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Supply Chain Analysis

Table 4: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Raw Material Providers

Table 5: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Resource Providers

Table 6: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Manufacturers (Suppliers)

Table 7: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Distributors And Channel Partners

Table 8: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Key Technologies & Future Trends

Table 9: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Trends

Table 10: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major End Users

Table 11: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Hepatitis B Virus (HBV) Capsid Inhibitors Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Hepatitis B Virus (HBV) Capsid Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market - TAM, US$ Billion, 2025

Table 15: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Core Protein Allosteric Modulators (CpAMs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Capsid Assembly Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Hepatitis B Virus (HBV) Capsid Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market - Company Scoring Matrix

Table 98: Johnson & Johnson Financial Performance

Table 99: Roche Holding AG Financial Performance

Table 100: GlaxoSmithKline plc Financial Performance

Table 101: Gilead Sciences Inc. Financial Performance

Table 102: Jiangsu Hengrui Pharmaceuticals Co. Ltd. Financial Performance

Table 103: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Competitive Dashboard

Table 105: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 107: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 108: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Overview Of Key Products - Product Examples

Figure 2: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Supply Chain Analysis

Figure 4: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Raw Material Providers

Figure 5: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Resource Providers

Figure 6: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Manufacturers (Suppliers)

Figure 7: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Distributors And Channel Partners

Figure 8: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Key Technologies & Future Trends

Figure 9: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major Trends

Figure 10: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Major End Users

Figure 11: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Hepatitis B Virus (HBV) Capsid Inhibitors Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Hepatitis B Virus (HBV) Capsid Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market - TAM, US$ Billion, 2025

Figure 15: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Core Protein Allosteric Modulators (CpAMs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Capsid Assembly Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Hepatitis B Virus (HBV) Capsid Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Hepatitis B Virus (HBV) Capsid Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market - Company Scoring Matrix

Figure 98: Johnson & Johnson Financial Performance

Figure 99: Roche Holding AG Financial Performance

Figure 100: GlaxoSmithKline plc Financial Performance

Figure 101: Gilead Sciences Inc. Financial Performance

Figure 102: Jiangsu Hengrui Pharmaceuticals Co. Ltd. Financial Performance

Figure 103: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market, Competitive Dashboard

Figure 105: Global Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 107: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 108: Global, Hepatitis B Virus (HBV) Capsid Inhibitors Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Chronic Hepatitis B Market Report 2026 - Global Outlook – By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online P...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Hepatitis Drugs Market Report 2026 - Global Outlook – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase Or NS5A Inhibitor Combinations, Hepatitis C Protease Or NS5A Inhibitor Combinations, NS5A Inhibitor...

Viral Hepatitis Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis), By Treatment (...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Alcoholic Hepatitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Supportive And Nutritional Therapy), By Route Of Administration (Oral, Injectable), By Severity Of Disease (Mild Alcoho...

Frequently Asked Questions

How big is the Hepatitis B Virus (HBV) Capsid Inhibitors Market?

The Hepatitis B Virus (HBV) Capsid Inhibitors market was valued at $0.52 billion in 2025, increased to $0.59 billion in 2026, and is projected to reach $0.98 billion by 2030.

What is the Hepatitis B Virus (HBV) Capsid Inhibitors market growth?

The global Hepatitis B Virus (HBV) Capsid Inhibitors market is expected to grow at a CAGR of 13.4% from 2026 to 2035 to reach $0.98 billion by 2035.

Who are the key players in Hepatitis B Virus (HBV) Capsid Inhibitors market?

Some Key Players in the Hepatitis B Virus (HBV) Capsid Inhibitors market Include, Johnson & Johnson, Roche Holding AG, GlaxoSmithKline plc, Gilead Sciences Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Novotech Health Holdings Pte. Ltd, Enanta Pharmaceuticals Inc., Assembly Biosciences Inc., Arbutus Biopharma Corporation, Aligos Therapeutics Inc., Qilu Pharmaceutical Co Ltd., Chia Tai Tianqing Pharmaceutical Group Co Ltd., Hepion Pharmaceuticals Inc., Shanghai Zhimeng Biopharma Inc., Antios Therapeutics, Bluejay Therapeutics Inc., Core Biopharma Inc., Door Pharmaceuticals, Shanghai Longwood Biopharmaceuticals Co. Ltd., Zhimeng Biopharma Inc. .

What is the anticipated growth trend for the Hepatitis B Virus (HBV) Capsid Inhibitors market?

Major trend in this market includes: Advancements In HBV Capsid Inhibitors Development. For further insights on this market. request a sample here

Which region has the most growth potential in the Hepatitis B Virus (HBV) Capsid Inhibitors market?

Asia-Pacific was the largest region in the hepatitis B virus (HBV) capsid inhibitors market in 2025. The regions covered in the hepatitis b virus (hbv) capsid inhibitors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.